Publications by authors named "Shrestha Ananta"

Claim this Profile
M
Modelling Micro-Elimination: Third-Trimester Tenofovir Prophylaxis for Perinatal Transmission of Hepatitis B in the Remote Dolpa District of Nepal.
Belaynew Taye, Patricia Valery, Shrestha Ananta, Sudhamshu Kc, Ivane Gamkrelidze

J Viral Hepat· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetes mellitus is linked to higher mortality in alcohol-related acute-on-chronic liver failure.
Ashish Kumar, Anil Arora, Praveen Sharma, Rakhi Maiwall, Ashok Choudhury, Ananta Shrestha

Hepatol Int· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Diabetes, Drug-Induced Liver Injury, and Sepsis on Outcomes in Metabolic Dysfunction Associated Fatty Liver Disease-Related Acute-on-Chronic Liver Failure.
Ashish Kumar, Anil Arora, Ashok Choudhury, Vinod Arora, Mohamed Rela, Ananta Shrestha

Am J Gastroenterol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute-on-chronic liver failure (ACLF): the 'Kyoto Consensus'-steps from Asia.
Ashok Choudhury, Anand V Kulkarni, Vinod Arora, A S Soin, Abdul Kadir Dokmeci, Ananta Shrestha

Hepatol Int· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subclinical hepatitis E virus genotype 1 infection: The concept of "dynamic human reservoir".
Ananta Shrestha, Suresh Basnet, Sudhamshu Kc

World J Hepatol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonalcoholic Fatty Liver Disease vs Metabolic-associated Fatty Liver Disease vs Metabolic Dysfunction-associated Steatotic Liver Disease: What's in the Name?
Shivaram P Singh, K C Sudhamshu, Prajna Anirvan, Ananta Shrestha, Mamun Al Mahtab

Euroasian J Hepatogastroenterol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asia-Pacific association for study of liver guidelines on management of ascites in liver disease.
Virendra Singh, Arka De, Rohit Mehtani, Paolo Angeli, Rakhi Maiwall, Ananta Shrestha

Hepatol Int· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
INASL-SAASL Consensus Statements on NAFLD Name Change to MAFLD.
Shivaram P Singh, Ajay Duseja, Mamun Al Mahtab, Prajna Anirvan, Subrat K Acharya, Ananta Shrestha

J Clin Exp Hepatol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Holistic Approach in the Management of Nonalcoholic Fatty Liver Disease.
Ananta Shrestha, Shrijana Pradhananga

Euroasian J Hepatogastroenterol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NAFLD vs MAFLD: South Asian NAFLD Patients don't Favor Name Change.
Shivaram P Singh, Prajna Anirvan, Amna S Butt, Ananta Shrestha, Anuradha S Dassanayake

Euroasian J Hepatogastroenterol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
'
'First week' is the crucial period for deciding living donor liver transplantation in patients with acute-on-chronic liver failure.
Ashok Choudhury, Rajan Vijayaraghavan, Rakhi Maiwall, Manoj Kumar, Zhongping Duan, Ananta Shrestha

Hepatol Int· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implications of Birth-Dose Vaccination against Hepatitis B Virus in Southeast Asia.
Sheikh Mohammad Fazle Akbar, Mamun Al Mahtab, Ferdousi Begum, Shaikh A Shahed Hossain, Sukumar Sarker, Ananta Shrestha

Vaccines (Basel)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of metabolic risk factors on the severity and outcome of patients with alcohol-associated acute-on-chronic liver failure.
Ajay Duseja, Arka De, Sunil Taneja, Ashok Kumar Choudhury, Harshad Devarbhavi, Ananta Shrestha

Liver Int· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis E should be considered a neglected tropical disease.
Andrew S Azman, Iza Ciglenecki, Joseph F Wamala, Julia Lynch, Rakesh Aggarwal, Ananta Shrestha

PLoS Negl Trop Dis· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-Induced Acute-on-Chronic Liver Failure in Asian Patients.
Harshad Devarbhavi, Ashok Kumar Choudhury, Manoj Kumar Sharma, Rakhi Maiwall, Mamun Al Mahtab, Ananta Shrestha

Am J Gastroenterol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short article: Association between liver fibrosis and hepatitis E seroprevalence among HIV-positive individuals in Nepal.
Shemal M Shah, Jagat B Baniya, Birendra Prasad Gupta, Ananta Shrestha, Holly Rodin

Eur J Gastroenterol Hepatol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver Cancer in Nepal.
Ananta Shrestha

Euroasian J Hepatogastroenterol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and risk of hepatitis E virus infection in the HIV population of Nepal.
Ananta Shrestha, Anurag Adhikari, Manjula Bhattarai, Ramanuj Rauniyar, Jose D Debes

Virol J· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Treatment of Acute and Chronic Hepatitis E Virus Infection: Role of Antivirals.
Ananta Shrestha, Birendra P Gupta, Thupten K Lama

Euroasian J Hepatogastroenterol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute hepatitis E virus infection in human immunodeficiency virus-positive men and women in Nepal: Not quite a rare entity.
Birendra Prasad Gupta, Ananta Shrestha, Anurag Adhikari, Thupten Kelsang Lama, Binaya Sapkota

Hepatology· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune therapy for hepatitis B.
Sheikh Mohammad Fazle Akbar, Mamun Al-Mahtab, Md Sakilur Islam Khan, Ruksana Raihan, Ananta Shrestha

Ann Transl Med· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First report of hepatitis E virus viremia in healthy blood donors from Nepal.
Birendra Prasad Gupta, Thupten K Lama, Anurag Adhikari, Ananta Shrestha, Ramanuj Rauniyar

Virusdisease· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viral Hepatitis in Nepal: Past, Present, and Future.
Ananta Shrestha

Euroasian J Hepatogastroenterol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis E epidemic, Biratnagar, Nepal, 2014.
Ananta Shrestha, Thupten K Lama, Sneha Karki, Deepak R Sigdel, Utsav Rai

Emerg Infect Dis· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology of Viral Hepatitis and Liver Diseases in Nepal.
Ananta Shrestha

Euroasian J Hepatogastroenterol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis